149 related articles for article (PubMed ID: 2944369)
1. Enoximone (MDL 17,043) for stable, chronic heart failure secondary to ischemic or idiopathic cardiomyopathy.
Weber KT; Janicki JS; Jain MC
Am J Cardiol; 1986 Sep; 58(7):589-95. PubMed ID: 2944369
[TBL] [Abstract][Full Text] [Related]
2. Positive inotropic therapy for short-term support and long-term management of patients with congestive heart failure: hemodynamic effects and clinical efficacy of MDL 17,043.
Uretsky BF; Valdes AM; Reddy PS
Circulation; 1986 Mar; 73(3 Pt 2):III219-29. PubMed ID: 2935328
[TBL] [Abstract][Full Text] [Related]
3. Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure.
Weber KT; Janicki JS; Jain MC
J Heart Transplant; 1986; 5(2):105-12. PubMed ID: 2956397
[TBL] [Abstract][Full Text] [Related]
4. Long-term oral enoximone therapy in chronic cardiac failure.
Maskin CS; Weber KT; Janicki JS
Am J Cardiol; 1987 Aug; 60(5):63C-67C. PubMed ID: 2956871
[TBL] [Abstract][Full Text] [Related]
5. Myocardial energetics and clinical response to the cardiotonic agent MDL 17043 in advanced heart failure.
Martin JL; Likoff MJ; Janicki JS; Laskey WK; Hirshfeld JW; Weber KT
J Am Coll Cardiol; 1984 Nov; 4(5):875-83. PubMed ID: 6238075
[TBL] [Abstract][Full Text] [Related]
6. [Enoximone, vasodilator and/or inotropic agent in congestive cardiac insufficiency? Hemodynamic and ventriculographic study of 20 cases].
Durrieu C; Rochoux G; Coste P; Le Goff G; Besse P
Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():43-50. PubMed ID: 2147834
[TBL] [Abstract][Full Text] [Related]
7. Comparison of acute hemodynamic response to dobutamine and intravenous MDL 17,043 (enoximone) in severe congestive heart failure secondary to ischemic cardiomyopathy or idiopathic dilated cardiomyopathy.
Likoff MJ; Ulrich S; Hakki A; Iskandrian AS
Am J Cardiol; 1986 Jun; 57(15):1328-34. PubMed ID: 2940855
[TBL] [Abstract][Full Text] [Related]
8. Placebo-controlled study of oral enoximone in congestive heart failure with initial and final intravenous hemodynamic evaluation.
Khalife K; Zannad F; Brunotte F; Belhadj K; Juilliere Y; Iannascoli F; Gilgenkrantz JM
Am J Cardiol; 1987 Aug; 60(5):75C-79C. PubMed ID: 2956874
[TBL] [Abstract][Full Text] [Related]
9. Comparative hemodynamic effects of intravenous dobutamine and MDL-17,043, a new cardioactive drug, in severe congestive heart failure.
Amin DK; Shah PK; Shellock FG; Hulse S; Brandon G; Spangenberg R; Swan HJ
Am Heart J; 1985 Jan; 109(1):91-8. PubMed ID: 3155585
[TBL] [Abstract][Full Text] [Related]
10. Acute hemodynamic response to low dose enoximone (MDL 17,043): an oral dose-range study.
Gilbert EM; Bristow MR; Mason JW
Am J Cardiol; 1987 Aug; 60(5):57C-62C. PubMed ID: 2956870
[TBL] [Abstract][Full Text] [Related]
11. [Enoximone/dobutamine comparison in chronic congestive cardiac insufficiency with low cardiac output].
Galinier M; Rochiccioli JP; Edouard P; Fourcade J; Massabuau P; Puel J; Fauvel JM; Bounhoure JP
Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():27-32. PubMed ID: 2147831
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects on hemodynamics of enoximone (MDL 17,043), dobutamine and nitroprusside in severe congestive heart failure.
Installé E; Gonzalez M; Jacquemart JL; Collard P; Roulette F; Pourbaix S; Tremouroux J
Am J Cardiol; 1987 Aug; 60(5):46C-52C. PubMed ID: 2956868
[TBL] [Abstract][Full Text] [Related]
13. Piroximone (MDL 19,205) in the treatment of unstable and stable chronic cardiac failure.
Weber KT; Janicki JS; Jain MC
Am Heart J; 1987 Oct; 114(4 Pt 1):805-13. PubMed ID: 3310566
[TBL] [Abstract][Full Text] [Related]
14. Comparative hemodynamic and hormonal response of enoximone and dobutamine in severe congestive heart failure.
Uretsky BF; Generalovich T; Verbalis JG; Valdes AM; Reddy PS
Am J Cardiol; 1986 Jul; 58(1):110-6. PubMed ID: 2942027
[TBL] [Abstract][Full Text] [Related]
15. Effects of low dose enoximone for chronic congestive heart failure.
Jessup M; Ulrich S; Samaha J; Helfer D
Am J Cardiol; 1987 Aug; 60(5):80C-84C. PubMed ID: 2956875
[TBL] [Abstract][Full Text] [Related]
16. Chronic therapy of severe heart failure with enoximone.
Gilfrich HJ; Witzke-Gross J; Römer A
J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S75-7. PubMed ID: 2480490
[TBL] [Abstract][Full Text] [Related]
17. Intravenous and oral MDL 17043 (a new inotrope-vasodilator agent) in congestive heart failure: hemodynamic and clinical evaluation in 38 patients.
Kereiakes D; Chatterjee K; Parmley WW; Atherton B; Curran D; Kereiakes A; Spangenberg R
J Am Coll Cardiol; 1984 Nov; 4(5):884-9. PubMed ID: 6238076
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of chronic cardiac insufficiency with intravenous bolus enoximone. Study of a pharmacokinetic-hemodynamic relation].
Gibelin P; Garraffo R; Sbirrazzuoli V; Lapalus P; Morand P
Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():75-81. PubMed ID: 2147839
[TBL] [Abstract][Full Text] [Related]
19. Acute hemodynamic effect of oral MDL 17,043 in severe congestive heart failure.
Uretsky BF; Generalovich T; Reddy PS; Salerni R; Valdes AM; Spangenberg RB; Lang JF; Okerholm RA
Am J Cardiol; 1984 Aug; 54(3):357-62. PubMed ID: 6235735
[TBL] [Abstract][Full Text] [Related]
20. MDL 17,043: short- and long-term cardiopulmonary and clinical effects in patients with heart failure.
Rubin SA; Tabak L
J Am Coll Cardiol; 1985 Jun; 5(6):1422-7. PubMed ID: 3158690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
